Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to the new market research report "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) Product (Imaging System, Camera, Lens, Software) Therapeutic Area (Ophthalmology, Oncology, Dermatology), Application (Pathological, Intra-operative), End user (Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Optical Imaging Market is projected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 14.8% during the forecast period.Browse in-depth TOC on "Optical Imaging Market"193 – Tables44 – Figures232 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=894 Factors such as the rising aging population, increasing research & development activities in the life sciences sector, and increasing applications of optical imaging techniques in drug discovery processes and preclinical research are fueling the growth of this market.This study analyzes the Optical imaging market based on their product, application, therapeutic area, imaging technique, and end-user.OCT segment to have the largest share in 2020Based on technique, the optical imaging market is broadly categorized into optical coherence tomography (OCT), hyper spectral imaging (HIS), near-infrared spectroscopy (NIRS), and photoacoustic tomography (PAT).The OCT technique commanded the largest share of the global market; this segment will continue to dominate the global market by 2026.The large share of this market can be attributed to its wide acceptance for research and clinical diagnostics in ophthalmology, oncology, cardiology, dermatology, neurology, and other clinical areas.The imaging system segment accounted for the largest market share in 2020Based on products, the optical imaging market is divided into imaging systems, cameras, software, lenses, illumination systems, and others.The large share of this segment is mainly attributed to its wide applications in ophthalmology and rising adoption in medical diagnostics & clinical research.Pathological Imaging was the largest application for the market in 2020Based on application, the optical imaging market is divided into pathological imaging and intra operative imaging.The large share of this segment is mainly attributed to the high-resolution imaging capabilities of optical imaging technologies, its non-invasive nature, and the increasing use of optical imaging in clinical applications.Ophthalmology was the largest therapeutic area for the Optical imaging market in 2020Based on therapeutic area, the market is divided into ophthalmology, oncology, cardiology, neurology, dermatology, and others.The large share of this segment is mainly attributed to the large application areas of optical imaging in ophthalmology.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=894 Some of the prominent players in this market are Carl Zeiss Meditec AG (Germany), Abbott Laboratories (US), Topcon Corporation (Japan), Canon Inc. (Japan), and Koninklijke Philips (Netherlands).About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.
According to the new market research report "Spirometer Market by Product (Device, Consumables and Accessories, Software), Mechanism(Flow Sensor, Peak Flow Meter), Application(COPD, Asthma), End User(Hospital, Clinical Laboratory, Homecare, Industrial Setting) - Global Forecast to 2025", published by MarketsandMarkets™, the Spirometer Market is expected to reach $1,285 million by 2025 from $799 million in 2020, at a CAGR of 11.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659 Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition.The consumables and accessoriessegment accounted for the largest share of the spirometermarket, by product segment, in 2019Based on product, the Spirometer Market is segmented into devices, consumables & accessories, and software.The consumables and accessories segment accounted for the largest share of the market in 2019.The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.Browse in-depth TOC on "Spirometer Market"198 – Tables24 – Figures  158 – PagesHospitals segment to register the highest growth rate during the forecast period.Based on end user, the market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings.Rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced spirometer devices are the factors driving the growth to this market during the forecasted period.North America is the largest regional market for Spirometer MarketThe global market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).The large share of this market segment can be attributed to the increasing incidence of chronic respiratory diseases and the rising adoption of technologically advanced devices in the region.Request For Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18015659 The major players operating in this Spirometer Market are Hill-Rom, Inc. (US), Midmark Corp. (US), Futuremed (US), COSMED (Italy), MGC Diagnostics Corporation (US), Vyaire Medical (US), Medical International Research (Italy),Vitalograph (UK), ndd Medical Technologies (Zurich), Inc., Schiller AG (Switzerland), Jones Medical Instrument Company (US), Sibelmed (Spain), MIR, Recorders and Medicare Systems (India), Smiths Medical (US), Medline (US), Teleflex (US), CONTEC (China), Fysiomed (Belgium), Medikro (Finland), Sdi Diagnostics (US), CHEST M.I.(Japan), Inc, FUKUDA SANGYO Co. Ltd. (Japan), Clarity Medical (India), and Guangzhou Medsinglong Medical Equipment Co., Ltd. (China).About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.
According to the new market research report "X-Ray Detector Market by Type (FPD, CSI, Gadox, CCD, Line scan), Panel (Small, Large), Portability (Fix, Portable), System (New, Retrofit), Application (Medical, Orthopedic, Mammogram, Dental, Cardiac, Veterinary, Security) - Global Forecast to 2024", published by MarketsandMarkets™, the X-Ray Detector Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984 Market growth is mainly driven by the growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays.The growth in this market is mainly driven by the advantages offered by FPD-based portable digital systems (such as high-quality images, faster scanning, increased patient throughput, and multiple storage options), their decreasing prices, and the growing demand for retrofit FPD-based digital X-ray systems.Browse in-depth TOC on "X-Ray Detector Market"256 – Tables41 – Figures  214 – Pages  Medical applications to register the highest growth in the X-Ray Detector Market during the forecast period.By application, the X-Ray Detector Market is segmented into medical, dental, security, veterinary, and industrial applications.The growth in this segment can primarily be attributed to the advancements in medical technology, rising geriatric population, and the increasing number of orthopedic and cardiovascular procedures.North America will continue to dominate the X-Ray Detector Market during the forecast periodIn 2019, North America is expected to account for the largest share of the X-Ray Detector Market.Factors such as advancements in healthcare infrastructure, technological advancements, and favorable venture capital funding are expected to fuel the market growth in this region.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=7004984 The X-Ray Detector Market is highly competitive with the presence of several small and big players.Some of the prominent players in the X-Ray Detector Market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Analogic Corporation (US), Rayence (South Korea), and Hamamatsu Photonics K.K.(Japan).About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.
According to a new market research report "Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021" published by MarketsandMarkets, the market is expected to reach USD 10.31 Billion by 2021 from USD 7.16 Billion in 2016, at a CAGR of 7.6% during the forecast period.Browse 103 market data Tables and 49 Figures spread through 151 Pages and in-depth TOC on "Coronary Stent Market"Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=77411272 This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).The growth of this market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population.Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market.However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.The report segments the Coronary Stent Market based on type, mode of delivery, material, end user, and region.This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications.Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77411272 The Coronary Stent Market is a highly fragmented market, with several big and emerging players.
According to a new market research report "Medical Image Management Market by Product (PACS (Departmental, Radiology, Mammography, Cardiology, Enterprise), VNA (On-premise, Hybrid, Cloud), AICA, Universal Viewer), End User (Hospitals, Diagnostic Imaging Centers, ASC, CRO) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.Browse 246 market data Tables and 39 Figures spread through 223 Pages and in-depth TOC on "Medical Image Management Market"Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=240573338  Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the Medical Image Management Market.The PACS segment is expected to dominate the Medical Image Management Market in 2018.Factors such as technological advancements in PACS; adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging healthcare IT adoption are driving the growth of the PACS segment.Based on procurement model, the enterprise PACS segment is projected to grow at the highest CAGR during the forecast period.This large share can be attributed to the fact that that PACS were originally designed keeping in mind individual departmental workflows and hence a large number of PACS were adopted in healthcare facilities.The enterprise PACS market, however, is expected to register the highest CAGR of during the forecast period owing to its ability to allow interoperability by allowing integration of results across different hospital departments, enabling seamless access to all patient information at a single point of interaction.The hospitals segment is expected to dominate the Medical Image Management Market in 2018.The Medical Image Management Market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users including ambulatory surgical centers (ASCs), small clinics, and contract research organizations (CROs).The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, increasing digitization of patient data, and rapid growth in EMR adoption are some of the major factors responsible for the large share of the hospitals segment in the market.North America to dominate the market in 2018 In 2018, North America is expected to command the largest share of the market.
According to a new market research "Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021", published by MarketsandMarkets, the global Cancer Immunotherapy Market is expected to reach USD 119.39 Billion by 2021 from USD 61.9 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021.Factors such as increasing incidence of cancer and rising healthcare expenditure are driving the growth of this market.Browse 43 market data Tables and 69 Figures spread through 145 Pages and in-depth TOC on "Cancer Immunotherapy Market"Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894In this report, the global Cancer Immunotherapy Market has been segmented based on type, application, end user, and region.The monoclonal antibodies segment is expected to account for the largest share of the market in 2016, while the checkpoint inhibitors segment is projected to witness the highest CAGR from 2016 to 2021.The rise in healthcare spending has resulted in the increasing use of immunotherapeutic drugs in hospitals.Based on regions, the global Cancer Immunotherapy Market is segmented into North America, APAC, Europe, and the Rest of the World (RoW).Growth in this regional segment is driven by factors such as increase in patient pool and initiative taken by the government for the development of cancer immunotherapy.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197577894Key players in the Cancer Immunotherapy Market include Amgen (U.S.), AstraZeneca (U.K.), F. Hoffmann-La Roche AG (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
According to the new market research report "Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Genome Engineering Market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.However, the high cost of genomic equipment will restrain the growth of this market.By technology, the CRISPR segment accounted for the largest share for the genome editing market.The CRISPR technology segment accounted for the largest share of the genome editing/genome engineering industry in 2019.Another potential advantage is its ability to multiplex.Browse in-depth TOC on "Genome Engineering Market"154 – Tables28 – Figures 147 – PagesBy end user, the pharmaceutical companies segment accounted for the largest share of the market.Pharmaceutical companies accounted for the largest share of the genome editing/genome engineering market, by end user, in 2019.The increasing prevalence of infectious diseases and cancer are driving research activities worldwide.A number of factors, such as the increased funding from governments and private organizations, growing industry focus on stem cell research, and global awareness are driving market growth in this segment.Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231037000North America accounted for the largest share of the market.The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW).Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
According to the new market research report "Hyperspectral Imaging System Market by Product (Camera, Accessories), Technology (Snapshot, Push broom), Application (Military, Remote Sensing (Agriculture, Mining, Environmental), Machine Vision, Life Sciences & Medical Diagnosis) - Global Forecast to 2025", published by MarketsandMarkets™, the Hyperspectral Imaging System Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The growing industrial applications of hyperspectral imaging and increasing funding and investments are the major factors driving the growth of this market.In 2019, the cameras segment accounted for the largest share of the marketOn the basis of product, the Hyperspectral Imaging Systems Market is segmented into cameras and accessories.Technological advancements, the development of affordable hyperspectral imaging cameras, and the increasing adoption of hyperspectral technology for defense and industrial applications are driving the growth of the hyperspectral cameras segment.Browse in-depth TOC on "Hyperspectral Imaging System Market"239 – Tables22 – Figures  195 – PagesThe Snapshot technology segment is expected to grow at the highest CAGR during the forecast periodBased on technology, the Hyperspectral Imaging Systems Market is segmented into pushbroom (line-scanning), snapshot (single shot), and other technologies [whiskbroom (point-scanning), tunable filters (wavelength scan), and imaging FTIR (time scanning)].The pushbroom segment is estimated to account for the largest share of the market in 2019, while the snapshot segment is projected to register the highest CAGR during the forecast period.This can be attributed to the advantages offered by snapshot hyperspectral imaging systems, which make this technology most suitable for real-time analysis.North America was the largest regional market for market in 2019The global Hyperspectral Imaging Systems Market has been divided into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).Factors such as growth in research funding, technological advancements, and increasing awareness of the benefits of hyperspectral imaging in commercial industries across the region are driving the market for hyperspectral imaging systems in North America.Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343 The prominent players operating in the Hyperspectral Imaging System Market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), BaySpec, Inc. (US), Cubert GmbH (Germany), inno-spec GmbH (Germany), XIMEA GmbH (Germany), imec (Belgium), and ChemImage Corporation (US).About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
According to the new market research report "Spatial Genomics and Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Drug Discovery),End User (Academic Institute, Research Institutes, CROs)-Global Forecast to 2025", published by MarketsandMarkets™, the Global Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.Browse in-depth TOC on "Spatial Genomics and Transcriptomics Market"218 – Tables29 – Figures201 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical RSpatial Transcriptomics techniques accounted for the largest share of the spatial genomics marketBased on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques.In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global transcriptomics market.Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.Academic & Research Institutes is the fastest-growing end-user segment of the marketBased on end-users, the spatial genomics market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies.Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.North America accounted for the largest share of the transcriptomics marketNorth America held the largest share in the global market, followed by Europe, with a share of 21.6%.The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics market in this region.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17090055110X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market.Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of the leading players in the market to gain a competitive edge in the market.About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.
According to research report the global MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth.By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.Based on type of surgery, the global minimally invasive surgical instruments market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries.The cardiothoracic surgery segment accounted for the largest share of the global MIS devices market in 2018.The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.Handheld instruments accounted for the largest share of the global MIS instruments market in 2018.Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments.Handheld instruments accounted for the largest share of the MIS devices market in 2018, owing to factors such as the increasing number of surgical procedures and the development of high-dexterity, low-cost articulating laparoscopic handheld surgical instruments.The hospital segment accounted for the largest share of the global minimally invasive surgical instruments market in 2018.Based on end user, the global MIS devices market is divided into hospitals and ambulatory surgery centers & clinics.The hospitals segment accounted for the largest share of the market in 2018 due to the large number of minimally invasive surgical procedures performed in hospitals owing to the presence of highly skilled healthcare professionals.The major companies in the global minimally invasive surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=682The MIS instruments market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW).North America accounted for the largest share of the global minimally invasive surgical instruments market, followed by Europe.
According to the new market research report the Spinal Implants Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 This market is primarily driven by the launch of advanced bone grafting products, the advancements in spine surgery technologies, increasing incidence of spinal disorders and the increasing adoption of minimally invasive spine surgeries.The major players operating in the Spinal Surgery Devices Market are Medtronic (Ireland), DePuy Synthes (US), Orthofix International N.V. (US), Abbott Laboratories (US), NuVasive, Inc. (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), RTI Surgical, Inc. (US), Boston Scientific (US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co. KG (Germany), Spineart (Switzerland), Kuros Biosciences AG (Switzerland), Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US), and Implanet (France).Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators.The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the market in 2019.The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.
According to the new market research report Interventional Cardiology Market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548The Growth in the Interventional Cardiology Devices Market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries.The old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019.Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons.In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market.The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.Thrombectomy devices segment accounted for the largest share of the plaque modification devices market in 2019.Based on type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices.In 2019, the thrombectomy devices segment accounted for the largest share of the plaque modification devices market.Growth in this market segment can largely be attributed to the increasing incidence of blood clots and atrial embolisms across the globe.North America accounted for the largest share of the interventional cardiology market in 2019.North America accounted for the largest share of the interventional cardiology market in 2019.The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the growing geriatric population, and the strong presence of industry players in the region.Opportunity: Emerging MarketsIndia, China, and Brazil are relatively untapped markets for interventional cardiology.
According to market research report Weight Loss Management Market to grow from USD 175.94 billion in 2017 to USD 245.51 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements.In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market.Growth in this segment is majorly driven by the growing diabetic population across the globe.By equipment, the weight loss management market is segmented into fitness equipment and surgical equipment.The fitness equipment segment is estimated to register the highest growth rate during the forecast period.The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.Based on service, the weight loss and weight management market is further segmented into fitness centers, slimming centers, consulting services, and online weight loss programs.The service segment is expected to grow at the highest CAGR during the forecast period.In 2017, North America is expected to dominate the global weight loss management market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region.
According to the market research report Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350Some of the key factors driving the growth of this market include increasing preference for noninvasive procedures, increasing prevalence of cancer and availability of funding for liquid biopsy RThe key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017.Based on clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring.The therapy selection segment is expected to account for the largest share of the liquid biopsy devices market in 2017.This is due to the ability of therapy selection to detect advanced-stage cancers (stage III and IV), followed by increasing studies on liquid biopsy and advancements made in this field to also aid in detection of early-stage cancers.By application, the cancer segment is expected to account for the largest market share in 2017.Based on application, the market is segmented into cancer and non-cancer applications (which includes reproductive health and organ transplant diagnostics).In 2017, cancer applications segment is expected to account for the largest share of the liquid biopsy market.By circulating biomarkers, circulating tumor cells is expected to account for the largest market share in 2017.
According to market research report the Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population.Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers.In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market.The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology.However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies.The most widely used technology in the Hemostasis Analyzer Market is the optical technology.
According to research report the global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4%Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population, and rising focus on cost containment in healthcare delivery are driving the greater uptake of mobile technologies.The Patches product segment accounted for the largest share of the Medical Wearable market in 2019Based on product type, the patches segment accounted for the largest share of the Clinical Wearable Market in 2019.The large share of this segment can be there have been significant technological advancements in medical wearable devices, which have helped improve the treatment outcomes for patients.Growing use of high-tech devices that are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables.These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.The vital sign monitoring device segment accounted for the largest share of the Clinical-Grade Wearable market in 2019Based on device type, the vital sign monitoring segment accounted for the largest share of the Clinical Wearable Market in 2019.Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.The Long-term care centers, nursing homes, and assisted-living facilities segment accounted for the largest share and highest growth of the Clinical-Grade Wearable market in 2019Based on the Clinical grade wearables market by end-user, the end-user is segmented into Long-term Care Centers/ Assisted Living Facilities/Nursing Homes, Hospitals, Ambulatory Care Centers, and Home/Patients.In 2019, the Long-term Care Centers/ Assisted Living Facilities/Nursing Homes accounted for the largest share and highest growth of the Medical Wearable market.
According to the new market research report Artificial Intelligence In Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market.However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.Based on offering, the Artificial Intelligence In Genomics Market is segmented into software and services.The software and services segment accounted for largest share of the global AI in genomics market in 2019.Software is needed to generate new insights from large-scale datasets and help understand genomic variations, thus enhancing the search for disease-causing variants and reducing clinical analysis times.The benefits offered by AI in software are driving its adoption among end users.Based on functionality, the AI in genomics market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine.
According to the new market research report Ambulatory EHR Market is expected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, an increase in the COVID-19 patient volume, growing usage of EHR solutions, and the need to curtail healthcare costs.On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global market to a certain extent.The prominent players operating in the ambulatory EHR market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Medical Information Technology, Inc. (MEDITECH, US), CPSI (US), NextGen Healthcare Information Systems, LLC (US), eClinicalWorks (US), athenahealth, Inc. (US), Modernizing Medicine, Inc. (US), Medical Transcription Billing Corporation (MTBC, US), Amazing Charts, LLC (US), Greenway Health (US), eMDs, Inc. (US), NetSmart Technologies (US), and CureMD (US).The cloud-based solutions segment is projected to occupy the majority of the market share during the forecast period.Based on delivery mode, the hospital EHR market is segmented into on-premise and cloud-based solutions.In 2019, the cloud-based solutions segment accounted for the largest share of the market.The market is mainly driven by the advantages associated with cloud-based solutions, which include flexibility and cost reductions in healthcare delivery.Practice management application is the largest application segment in the marketOn the basis of application, the global market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics.The practice management segment commanded the largest share of the global ambulatory EHR market in 2019.The significant share of this application segment can primarily be attributed to the wide range of advantages associated with practice management solutions, including increased efficiency of day-to-day operations, enhanced value of services provided to patients, and improved adherence to compliance requirements.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235617627In 2019, North America accounted for the largest share of the market.The ambulatory EHR market is predominantly divided into five major geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l.(Italy), ELITechGroup (France), Mast Group Ltd. (UK), CONDALAB (Spain), Genefluidics, Inc. (US), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global Antimicrobial Susceptibility Testing Market.The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables.Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types.
According to the new market research report Tangential Flow Filtration Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024 at a CAGR of 11.0% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607Market growth is largely driven by factors such as increasing adoption of single-use technologies, advantages of tangential flow filtration over normal flow filtration and increased cGMP adoption.Based on material type, the global tangential flow filtration market is divided into PES/PS, regenerated cellulose, and other materials.The PES/PS segment is expected to account for the largest share of the global TFF market in 2019.The hydrophilic nature of PES/PS, its low protein-binding properties, and wide range of applications, such as ultrafiltration of downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions, is expected to drive the demand for this material.Tangential flow filtration systems segment to account for the largest share of the global TFF Market in 2019Based on the product, the TFF System Market is segmented into systems, membrane filters, and accessories.The systems segment is expected to account for the largest share of the market in 2019, owing to factors such as the increasing use of different single-use systems among end users due to their advantages, such as a reduced need for product validation and cleaning.Bioprocess applications projected to account for the largest application segment of the market in 2019Based on application, the market is segmented into bioprocess applications, viral vector and vaccine purification, and other applications such as drug formulation, blood plasma fractionation, media and buffer preparation, and pharmaceutical water purification.The bioprocess applications segment is expected to dominate the market in 2019 owing to factors such as growth in the overall biopharmaceutical industry, increasing biologics research, and significant growth in biologics research funding.The major companies in the global TFF Market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), and Repligen Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72081607North America is projected to account for the largest share of the Tangential Flow Filtration Market in 2019In 2019, North America is expected to account for the largest share of the TFF System Market, followed by Europe.The largest share of the North American market is attributed to the presence of a well-established biopharmaceutical industry and significant R spending by pharmaceutical and biotechnology companies.
More

Top